Neuronetics Inc. STIM shares soared 41.08% to $2.06 in after-hours trading on Tuesday following preliminary fourth-quarter 2025 financial results. Revenue Climbs Across Both Segments The medical ...
Please provide your email address to receive an email when new articles are posted on . Anodal transcranial direct current stimulation, with exercise and patient education, improved disability caused ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic ...
Transcranial Magnetic Stimulation (TMS) is a safe, non-invasive procedure that delivers magnetic pulses to the brain to change neural activity. It is used to treat mental health disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results